Leon Wang
Stock Analyst at Barclays
(2.82)
# 1,831
Out of 4,910 analysts
11
Total ratings
71.43%
Success rate
18.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Leon Wang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSM Insmed | Maintains: Overweight | $40 → $63 | $103.52 | -39.14% | 5 | May 29, 2024 | |
| RAPT RAPT Therapeutics | Downgrades: Equal-Weight | $104 → $32 | $12.65 | +152.96% | 3 | May 10, 2024 | |
| MLTX MoonLake Immunotherapeutics | Maintains: Equal-Weight | $41 → $59 | $55.03 | +7.21% | 3 | Sep 12, 2023 |
Insmed
May 29, 2024
Maintains: Overweight
Price Target: $40 → $63
Current: $103.52
Upside: -39.14%
RAPT Therapeutics
May 10, 2024
Downgrades: Equal-Weight
Price Target: $104 → $32
Current: $12.65
Upside: +152.96%
MoonLake Immunotherapeutics
Sep 12, 2023
Maintains: Equal-Weight
Price Target: $41 → $59
Current: $55.03
Upside: +7.21%